have demonstrated that treatment of cetuximab resistant HNSCC cells with cetuximab did not result in the decreased levels of phosphorylated Akt that were seen in cetuximab sensitive HNSCC cells. The gene discussed is AKT1; the disease is head and neck squamous cell carcinoma.